TGF-Β1, PNPLA3 Genetic Variants and the Risk of Hepatic Fibrosis: Correspondence.
作者信息
Sookaromee Pathum, Wiwanitkit Viroj
机构信息
Private Academic Consultant, Bangkok Thailand.
Hainan Medical University, China.
出版信息
Asian Pac J Cancer Prev. 2021 Dec 1;22(12):4067. doi: 10.31557/APJCP.2021.22.12.4067.
Abstract
摘要
相似文献
1
TGF-Β1, PNPLA3 Genetic Variants and the Risk of Hepatic Fibrosis: Correspondence.
Asian Pac J Cancer Prev. 2021 Dec 1;22(12):4067. doi: 10.31557/APJCP.2021.22.12.4067.
2
TGF-Β1 & PNPLA3 Genetic Variants and the Risk of Hepatic Fibrosis and HCC in Egyptian Patients with HCV-Related Liver Cirrhosis.
Asian Pac J Cancer Prev. 2021 Oct 1;22(10):3317-3326. doi: 10.31557/APJCP.2021.22.10.3317.
3
Plasma concentration of transforming growth factor-beta1 and hepatic fibrosis in dogs.
Can J Vet Res. 2008 Oct;72(5):428-31.
4
Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
Hepatobiliary Pancreat Dis Int. 2009 Jun;8(3):300-8.
5
Active immunization against transforming growth factor beta1 prevents hepatic fibrosis in a rat model of liver disease.
Can J Physiol Pharmacol. 2017 Jun;95(6):743-749. doi: 10.1139/cjpp-2016-0669. Epub 2017 Mar 16.
6
Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.
Cell Physiol Biochem. 2017;43(6):2242-2252. doi: 10.1159/000484303. Epub 2017 Oct 27.
7
PNPLA3 overexpression results in reduction of proteins predisposing to fibrosis.
Hum Mol Genet. 2016 Dec 1;25(23):5212-5222. doi: 10.1093/hmg/ddw341.
8
Effects of Chinese traditional compound, JinSanE, on expression of TGF-beta1 and TGF-beta1 type II receptor mRNA, Smad3 and Smad7 on experimental hepatic fibrosis in vivo.
World J Gastroenterol. 2005 Apr 21;11(15):2269-76. doi: 10.3748/wjg.v11.i15.2269.
9
Transforming growth factor beta-1 upregulates glucose transporter 1 and glycolysis through canonical and noncanonical pathways in hepatic stellate cells.
World J Gastroenterol. 2021 Oct 28;27(40):6908-6926. doi: 10.3748/wjg.v27.i40.6908.
10
Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
Phytomedicine. 2020 Nov;78:153294. doi: 10.1016/j.phymed.2020.153294. Epub 2020 Jul 28.
本文引用的文献
1
TGF-Β1 & PNPLA3 Genetic Variants and the Risk of Hepatic Fibrosis and HCC in Egyptian Patients with HCV-Related Liver Cirrhosis.
Asian Pac J Cancer Prev. 2021 Oct 1;22(10):3317-3326. doi: 10.31557/APJCP.2021.22.10.3317.
2
Significance of Hereditary Hemochromatosis Gene (HFE) Mutations in Chronic Hepatitis C and Hepatocellular Carcinoma Patients in Egypt: A Pilot Study.
Asian Pac J Cancer Prev. 2021 Sep 1;22(9):2837-2845. doi: 10.31557/APJCP.2021.22.9.2837.
3
Association between MICA rs2596542 Polymorphism with the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients.
Pathol Oncol Res. 2020 Jul;26(3):1519-1525. doi: 10.1007/s12253-019-00738-6. Epub 2019 Aug 31.
Zotero 插件